Search results

7 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Five genetic regions implicated in cystic fibrosis severity
An international consortium of researchers conducted the largest-ever CF genome-wide analysis to find new therapeutic targets.
Located in News / 2015 / September
Scientists find gene linked to heightened mucus levels in lung disease
In lab experiments, UNC School of Medicine researchers showed that blocking the gene Bpifb1 led to a striking increase in the mucin protein MUC5B in mucus.
Located in News / 2017 / October
Are e-cigarettes ‘safer’ than regular cigarettes?
UNC School of Medicine researchers lead new study showing that e-cigarettes trigger unique and potentially damaging immune responses in human airways.
Located in News / 2017 / October
UNC lung researchers awarded $12.5-million NIH grant to develop new drug compounds
The National Institutes of Health has awarded four UNC experts a translational program project grant (tPPG) to develop and test therapeutics aimed at reducing the hyper-concentration of mucus often found in cystic fibrosis and asthma patients.
Located in News / 2017 / September
A New Test to Measure the Effectiveness of CF Drugs
A new lab model developed by UNC’s Carla Ribeiro, PhD, and colleagues can be used to test new therapeutics for cystic fibrosis.
Located in News / 2017 / November
CF Foundation honors UNC researchers for vital treatment
Hypertonic saline, developed into an effective treatment at UNC School of Medicine in collaboration with Australian researchers, has become a proven therapy for thousands of people with cystic fibrosis.
Located in News / 2014 / October
Increased mucins pinned to worsening cystic fibrosis symptoms
The discovery from UNC School of Medicine researchers overturns a controversial research study and offers a path for creating and testing CF treatments.
Located in News / 2014 / June